At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Importance of Understanding Provider Variability in the Use of Neuromuscular Blocking Drugs and Reversal Agents
In Brief
An observational study evaluating Neuromuscular blocking agents for Neuromuscular Blockade and 2 related conditions. Completed, enrolled 265,537 participants across 2 sites.
Detailed Summary
The use of neuromuscular blocking agents during surgery is associated with postoperative respiratory complications and increased risk of readmission to the hospital following ambulatory surgery. Understanding the clinical behavior of providers is essential in devising and assessing quality improvement projects since it is primarily individuals who determine the utilization of neuromuscular blocking drugs and reversal agents, not institutions. Therefore, the primary objective of this study is to determine the variability between individual anesthesia providers (attending physician, resident, nurse anesthetists) in the use of neuromuscular blocking drugs and reversal agents, using advanced statistical methods to adjust for differences in patient and procedure case mix. The investigators hypothesize that variance between individual anesthesia providers in the use of neuromuscular blocking drugs and reversal agents differs depending on provider type.
Study Details
Timeline
Interventions
Neuromuscular blocking agent ED95 equivalent dose by provider